World Intravenous Solutions Market Research Study:
Intravenous solutions are a complete mix of essential nutrients that are intended to replenish fluid losses, treat electrolyte imbalances and maintain fluid balance in intravenous therapy. They also provide required Supplements to the patients suffering from diabetes, cancer and other diseases. They may contain water with electrolytes, sugar or medications added in concentrations as per the patient’s need. In line with this, the rate and quantity of these solutions varies depending on the medical position, age and body size of the patient. Prevalence of diseases, such as gastrointestinal disorder, neurological diseases, cancer and diabetes, due to unhealthy eating habits is the key factor for the growth of the intravenous solutions market. Moreover, as these solutions are available in portable packages, it becomes easier for the patients to use the drips at the comfort of their home rather than a hospital. Manufacturers are coming up with new product innovations such as introducing premixed solutions for better convenience and to reduce the amount of packaging waste.
Browse TOC and other details of 107 pages World Intravenous Solutions Market Research Report @ https://www.researchcosmos.com/reports/world-intravenous-solutions-market-to-2021-global-analysis-and-forecasts/7389336
World Intravenous Solutions Market Size and Regional Analysis:
The global intravenous solution market was valued at $4940 million in 2017 and is estimated to grow at a CAGR of 6.2% till 2022 to reach $2375 million. The major markets for this segment are North America, Asia Pacific, Europe, and rest of the world. North America accounts for the majority of the total sales, followed by Europe and Asia Pacific. Asia-Pacific region is the fastest growing market for Intravenous Solution Market, which is expected to grow at a CAGR of 8.24% during the forecast period from 2017 to 2021.
Some of the Key Players in this Market Report:
This is due to the emergence of high-quality and better healthcare infrastructure and institutions in this region. Some of the key players in the global market are ICU Medical Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxte, Amanta Healthcare, Terumo Medical Corporation, Grifols S.A. and others.
Successive changes in regulatory authorities’ reimbursement policies have motivated hospitals to explore different methods of administering drugs through the intravenous process. Growing adoption of intravenous solutions has spurred the growth of the market, and it is expected that the market will advance with high growth rate, however, stringent government regulations might hinder the growth of the market.
IV solutions are manufactured under very rigorous guidelines to ensure patient safety. Increasing vitamin C intravenous therapy prices might also hamper the growth. However, the cost-effectiveness, increasing prevalence of chronic diseases, the rise of cholera and growing acceptance of vitamin C intravenous for colorectal cancer, rise in geriatric population, increase in number of dialysis patients, expanding healthcare expenditure and increasing government endorsement are a definite boost to the market for IV’s.
Research Cosmos is a provider of standard and customized Industry research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending Industry reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.
Company Name: Research Cosmos
Contact Person: Kevin Stewart
Email: Send Email
Address:4390 U.S 1, Suite 211
State: New Jersey
Country: United States